How many SC 13D/A filings has Genedx Holdings Corp. filed?

Genedx Holdings Corp. (WGSWW) has 10 SC 13D/A (SC 13D/A) filings on record, spanning May 2024 to Nov 2024.

What is a SC 13D/A filing?

A SC 13D/A is an SEC filing known as "SC 13D/A." It is filed with the SEC as a SC 13D/A.

Where can I read Genedx Holdings Corp. SC 13D/A filings in plain English?

ReadTheFiling provides AI-powered plain-English summaries of all Genedx Holdings Corp. SC 13D/A filings, including risk assessment, sentiment analysis, and key financial figures.

Genedx Holdings Corp. (WGSWW) — SC 13D/A Filings

All SC 13D/A filings from Genedx Holdings Corp.. Browse 10 SC 13D/A reports with AI-powered summaries and risk analysis.

SC 13D/A Filings (10)

OPKO Health Files 13D/A Amendment for GeneDx Holdings — Nov 20, 2024 Risk: medium
OPKO Health, Inc. has filed an amendment to its Schedule 13D, indicating a change in its beneficial ownership of GeneDx Holdings Corp. as of November 20, 2024.
Mount Sinai Files 13D/A for GeneDx Holdings — Nov 19, 2024 Risk: medium
On November 19, 2024, the Icahn School of Medicine at Mount Sinai filed Amendment No. 5 to its Schedule 13D for GeneDx Holdings Corp. (f/k/a Sema4 Holdings Corp
OPKO Health Amends GeneDx Holdings Stake Filing — Nov 8, 2024 Risk: medium
OPKO Health, Inc. has filed an amendment to its Schedule 13D, indicating a change in its beneficial ownership of GeneDx Holdings Corp. as of November 8, 2024. T
Mount Sinai Files 13D/A Amendment for GeneDx Holdings — Nov 4, 2024 Risk: medium
On November 4, 2024, Icahn School of Medicine at Mount Sinai filed an amendment (Amendment No. 4) to its Schedule 13D regarding GeneDx Holdings Corp. The filing
OPKO HEALTH, INC. Amends GeneDx Holdings Stake Filing — Sep 18, 2024 Risk: medium
OPKO HEALTH, INC. has amended its Schedule 13D filing regarding GeneDx Holdings Corp. as of September 18, 2024. The filing indicates a change in beneficial owne
OPKO Health Files 13D/A Amendment for GeneDx Holdings — Aug 23, 2024 Risk: medium
OPKO Health, Inc. has filed an amendment to its Schedule 13D, indicating a change in its beneficial ownership of GeneDx Holdings Corp. as of August 23, 2024. Th
OPKO Health Amends Filing for GeneDx Holdings Stake — Aug 12, 2024 Risk: medium
OPKO Health, Inc. has filed an amendment to its Schedule 13D, indicating a change in its beneficial ownership of GeneDx Holdings Corp. as of August 12, 2024. Th
OPKO Health Files 13D/A Amendment for GeneDx Holdings — Jul 26, 2024 Risk: medium
OPKO Health, Inc. has filed an amendment to its Schedule 13D, indicating a change in its beneficial ownership of GeneDx Holdings Corp. as of July 26, 2024. The
OPKO Health Files 13D/A for GeneDx Holdings Corp. — Jul 5, 2024 Risk: medium
OPKO Health, Inc. has filed an amendment to its Schedule 13D, indicating a change in its beneficial ownership of GeneDx Holdings Corp. as of July 5, 2024. The f
Corvex Management Ups GeneDx Stake to 10.4% — May 31, 2024 Risk: medium
CMLS Holdings LLC, managed by Corvex Management LP, has amended its Schedule 13D filing for GeneDx Holdings Corp. on May 31, 2024. The filing indicates a change

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX